Sentence and cancer type
Showing 61-80 of 146 items.
SentenceCancertype
Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1. None
Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. None
Ets1 oncogene induction by ELF-modulated 50 MHz radiofrequency electromagnetic field. None
The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter. None
Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis. None
PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. None
Expression of the ets-1 proto-oncogene in melanocytic lesions. None
The biology of the Ets1 proto-oncogene. None
XbaI RFLP of ETS-1 oncogene in chronic B-cell leukaemia. None
c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. None
A positive regulator of the ribosomal protein gene, beta factor, belongs to the ETS oncoprotein family. None
Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1. None
p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1.None
Molecular characterization and structural organization of D-elg, an ets proto-oncogene-related gene of Drosophila. None
Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. None
Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein. None
Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding. None
Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis. None
E1AF, an ets-oncogene family transcription factor. None
Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. None